Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

ACR Leads Coalition Response to HHS Proposed Drug Pricing Threats

Carina Stanton  |  April 20, 2018

Potential federal drug pricing proposals could shuffle Part B drug coverage into the Part D program and restructure reimbursements for new drugs, moves that would jeopardize patient access to care, explains Kent “Kwas” Huston, MD, a rheumatologist in Kansas City, Mo., and a member of the ACR’s Government Affairs Committee (GAC). “We believe Part D…

New Life for the Michigan Rheumatism Society

Kelly Tyrrell  |  April 20, 2018

Amar Majjhoo, MD, had just completed his rheumatology fellowship in 2005 when he attended his first meeting of the Michigan Rheumatism Society. “I thought it was exciting that we had a state society, because to me, everything was new,” says the Michigan-based, private practice rheumatologist. “Having a meeting where established doctors were sitting around was…

Sharing Knowledge to Support Care: A Conversation with ACR Communications & Marketing Committee Member Suleman Bhana, MD, FACR

Carina Stanton  |  April 20, 2018

Whether he is teaching rheumatologists how to leverage technology tools in their practice or working with the ACR’s Communications and Marketing Committee (CMC) to connect members with practice knowledge and support, Suleman Bhana, MD, FACR, a rheumatologist with Crystal Run Healthcare in Middletown, N.Y., is focused on connecting with his colleagues to improve patient care….

FDA Expands Label for Insulin Degludec; Adalimumab Biosimilar Moves Forward After Legal Battle

Michele B. Kaufman, PharmD, BCGP  |  April 18, 2018

The FDA has expanded the label for insulin degludec to include data on improved cardiovascular outcomes and deceased severe hypoglycemia…

Poor Sleep Quality During Menopause Tied to Increased Inflammation

Cheryl Platzman Weinstock  |  April 17, 2018

(Reuters Health)—Middle-aged women who get poor quality sleep have elevated levels of inflammatory markers, suggesting their risk for heart disease and other illnesses may be increased, U.S. researchers say. Based on sleep monitoring and blood tests of 295 women, most of whom were past menopause, researchers found those who had trouble falling asleep or who…

Data Show Outreach Is Working, But Does Rheumatology Have Enough Positions Available?

Richard Quinn  |  April 16, 2018

New data indicate that outreach is working: the interest of young medical professionals in rheumatology is growing. But as this interest grows, so will demand for rheumatology positions and funding for fellowships. The ACR has a plan to address these needs…

Nonopioid Medication May Be as Effective as Opioids for Chronic Pain

Lara C. Pullen, PhD  |  April 16, 2018

A recent study compared the efficacy of opioids with nonopioid pain treatments in patients with chronic back pain and hip or knee osteoarthritis. After 12 months, researchers found that treatment with opioids was not superior to treatment with nonopioid medication, with only minor differences in patients’ functional responses to the medications…

CVS Rolls Out New Tool to Combat Rising Drug Prices

Reuters Staff  |  April 12, 2018

(Reuters)—Drugstore chain CVS Health Corp on Wednesday launched a new tool that will allow pharmacies help customers tackle the soaring cost of drugs by comparing prices of medicines. U.S. healthcare companies, ranging from insurers to drug retailers, are stepping up efforts to combat rising drug prices that has been widely criticized by regulators and has…

ACR Named a Top Atlanta Workplace for 2nd Consecutive Year

Susan Bernstein  |  April 11, 2018

In a designation based on employee opinion, the ACR has been named one of the top places to work in Atlanta for the second year in a row. The honor is “a testament to the supportive and enthusiastic environment that we foster,” says ACR Executive Vice President Mark Andrejeski…

FDA to Review Abuse Deterrent Oxycodone Capsule & More

Michele B. Kaufman, PharmD, BCGP  |  April 11, 2018

The FDA will discuss a New Drug Application for Remoxy ER during an upcoming advisory committee meeting and recently approved tildrakizumab-asmn to treat adults with plaque psoriasis…

  • « Previous Page
  • 1
  • …
  • 347
  • 348
  • 349
  • 350
  • 351
  • …
  • 816
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences